Background The National Institute for Occupational Safety and Health (NIOSH) published in 2016 a list of hazardous drugs (HDs) that, due to their harmful effects on the organism,?require special handling. While the preventive measures taken by health professionals in their preparation and administration often correspond to the established recommendations, receiving and transporting them are less protocolised stages in the drug chain.
Purpose Implement a specific circuit of internal transport of antineoplastic HDs, from its reception to its storage, within the Pharmacy Department (PD).
Material and methods In February 2017, a multidisciplinary group of HD was established in a third-level hospital, to be approached and adapted according to current regulations.
We analysed the current situation and the ideal situation, to identify possible discrepancies and to be able to adopt improvement measures. It was reviewed which drugs in the hospital pharmacotherapeutic guide were antineoplastic HD. Once identified, it became clear that the reception and transportation measures to its place of storage, were not adequate to the recommendations. There were deviations in identification and preventative management measures.
Results A specific circuit for the reception and internal transport of antineoplastic HDs was established in the PD. At the level of the receipt of medicines, a list of them was elaborated. It included the active principal and commercial name of each of them. It also indicated the measures to be taken in case of need to be manipulated. On the other hand, labels were designed with a symbol that indicated the hazardous nature of the product. These labels were stuck in the boxes containing these medications. Once identified, the HDs were grouped together and separated from the rest of the drugs, and transported through an independent circuit in semi-enclosed containers that reduced the risk of breakage during transport. All the changes made were reflected in the respective standard logistic distribution procedures of the PD.
Conclusion A specific circuit for the reception and transport of antineoplastic HDs, based on the identification of products and the need to take preventative safety measures, guarantees the maximum safety of PD workers.
Reference and/or Acknowledgements 1. https://www.cdc.gov/niosh/topics/antineoplastic/pdf/hazardous-drugs-list_2016-161.pdf
No conflict of interest
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.